Diffusion-weighted imaging of prostate cancer

Area of Science:

• Radiology
• Medical Imaging
• Oncology

Background:

• Prostate cancer diagnosis relies heavily on Magnetic Resonance (MR) imaging.
• Conventional T2-weighted (T2W) imaging is a cornerstone of prostate MR interpretation.
• Limitations exist in differentiating cancerous tissue from healthy tissue using T2W imaging alone.

Purpose of the Study:

• To evaluate the efficacy of combining diffusion-weighted (DW) imaging with T2-weighted (T2W) imaging for prostate cancer detection.
• To compare the diagnostic performance of T2W imaging alone versus T2W imaging with DW imaging.
• To determine if the addition of DW imaging improves the accuracy of prostate cancer identification.

Main Methods:

• A study involving 60 patients (37 with prostate cancer, 23 without) undergoing 1.5-T MR imaging.
• All subjects received both T2W and DW imaging sequences with parallel imaging.
• Three independent readers assessed prostate cancer detectability, analyzed via receiver operating characteristic (ROC) analysis.

Main Results:

• The area under the ROC curve for T2W imaging alone was 0.87.
• The area under the ROC curve for T2W imaging with DW imaging was 0.93.
• Statistical analysis confirmed a significant improvement (P = 0.0468) in tumor detection with the addition of DW imaging.

Conclusions:

• Diffusion-weighted (DW) imaging significantly enhances the detection of prostate cancer when added to conventional T2-weighted (T2W) MRI.
• The combined T2W and DW imaging approach offers superior diagnostic performance compared to T2W imaging alone.
• This finding supports the integration of DW imaging into routine prostate cancer diagnostic protocols.